Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|March 1, 1996
A novel catecholamine, arbutamine, for a pharmacological cardiac stress agentR Nagarajan, G Abou-Mohamed, T Myers, et al.European Journal of Pharmacology|May 23, 1998
Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activityG Abou-Mohamed, A Papapetropoulos, J D Catravas, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 4, 2001
Endothelial cell dysfunction in a model of oxidative stressL Jin, G Abou-Mohamed, R B Caldwell, et al.Cardiovascular Drugs and Therapy|March 1, 1996
Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testingG Abou-Mohamed, R Nagarajan, T M Ibrahim, et al.Journal of Cardiovascular Pharmacology|March 1, 1994
Integrative cardiovascular actions of a novel catecholamine, GP-2-128G Abou-Mohamed, R W Caldwell, T M Ibrahim, et al.British Journal of Pharmacology|May 12, 2000
Role of L-arginine in the vascular actions and development of tolerance to nitroglycerinG Abou-Mohamed, W H Kaesemeyer, R B Caldwell, et al.Pharmacology|April 1, 1995
Effect of zinc on the anti-inflammatory and ulcerogenic activities of indometacin and diclofenacG Abou-Mohamed, H A el-Kashef, H A Salem, et al.Journal of Cardiovascular Pharmacology|March 1, 1994
Interactions of a novel catecholamine, GP-2-128, with adrenoceptorsG Abou-Mohamed, R W Caldwell, G O Carrier, et al.British Journal of Pharmacology|July 1, 1996
Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 betaA Papapetropoulos, G Abou-Mohamed, N Marczin, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitroG Abou-Mohamed, A Papapetropoulos, D Ulrich, et al.Pageof 2